Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | Cancer Vaccines Summit to be chaired by Dr Joseph Melenhorst from the University of PennsylvaniaCancer Vaccines 2014; Quantify Strategies to Enhance Cancer Vaccine Research and Development, 15th - 16 September, London UK
By: SMi Group Jos Melenhorst will be chairing the conference and will also be providing key insights into the "perfect partnership" The Product Development & Correlative Sciences Laboratory improves cellular immune therapy efficacy tracking the expansion, persistence, homing, and the quality of chimeric antigen receptor-expressing T (CART) cells, response of the tumor to therapy, and biomarkers of response. In addition Joseph Melenhorsts team assess the quality attributes of the starting material and end product of cell manufacturing again for markers that predict clinical efficacy. This information feeds back into cell manufacturing. When asked about the strengths of Cancer Vaccines 2014, Dr Melenhorst highlighted cutting edge tumor vaccine development plus insights into analytical methodologies that drive the improvement of cancer vaccines as key updates. “The most interesting sessions in this conference? Tough call to make since all sessions are incredibly exciting, but if I would have to make a choice it would be improving the success in vaccine research & development.” When asked what he thought the biggest challenges are in the industry today, he said: “Moving the proof-of-concept vaccines into a pre-emptive vaccination strategy. Vaccinating a patient who has a high tumor burden may be not the best timing of this approach. The future for cancer vaccines? Pre-emptive vaccination, adjuvants for response amplification/ The full interview is available to read in the event download tab at www.cancer-vaccinesevent.com Confirmed attendees include: Amal Therapeutics, Amgen, Boehringer Ingelheim RCV GmbH & Co KG, Breast International Group, Cancer Research UK, Cancer Vaccines Ltd, Crucell Vaccine Institute, Curevac GmbH, DanDrit Biotech, EGIS Pharmaceuticals, GSK, Hybrid Systems, Immatics Biotechnologies, Immudex, Immunicum, KACST, MediGene, Scancell, St George Hospital, Theravectys, University Of Pennsylvania, University Of Southampton, University Of Tuebingen, Vaccinogen, Valneva, XEME Biopharma plus many more.. For further details on Cancer Vaccines 2014, visit www.cancer-vaccinesevent.com Cancer Vaccines 15TH & 16TH SEPT 2014 Holiday Inn Regents Park, London UK www.cancer-vaccinesevent.com --end-- About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to- More information can be found at http://www.smi- End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|